These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9059138)

  • 21. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.
    Yli-Kerttula T; Luukkainen R; Yli-Kerttula U; Möttönen T; Hakola M; Korpela M; Sanila M; Parviainen J; Uksila J; Vainionpää R; Toivanen A
    Ann Rheum Dis; 2000 Jul; 59(7):565-70. PubMed ID: 10873968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of psoriatic arthritis with sulphasalazine: a one year open study.
    Farr M; Kitas GD; Waterhouse L; Jubb R; Felix-Davies D; Bacon PA
    Clin Rheumatol; 1988 Sep; 7(3):372-7. PubMed ID: 2906579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
    Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
    Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial.
    Capell HA; Madhok R; Hunter JA; Porter D; Morrison E; Larkin J; Thomson EA; Hampson R; Poon FW
    Ann Rheum Dis; 2004 Jul; 63(7):797-803. PubMed ID: 15194574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial.
    Gupta AK; Grober JS; Hamilton TA; Ellis CN; Siegel MT; Voorhees JJ; McCune WJ
    J Rheumatol; 1995 May; 22(5):894-8. PubMed ID: 8587078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.
    Danis VA; Franic GM; Rathjen DA; Laurent RM; Brooks PM
    Ann Rheum Dis; 1992 Aug; 51(8):946-50. PubMed ID: 1358037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfasalazine for ankylosing spondylitis.
    Chen J; Liu C
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004800. PubMed ID: 15846731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis.
    Mielants H; Veys EM; Joos R
    Clin Rheumatol; 1986 Jan; 5(1):80-3. PubMed ID: 2869851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.
    Ruperto N; Lovell DJ; Quartier P; Paz E; Rubio-Pérez N; Silva CA; Abud-Mendoza C; Burgos-Vargas R; Gerloni V; Melo-Gomes JA; Saad-Magalhães C; Sztajnbok F; Goldenstein-Schainberg C; Scheinberg M; Penades IC; Fischbach M; Orozco J; Hashkes PJ; Hom C; Jung L; Lepore L; Oliveira S; Wallace CA; Sigal LH; Block AJ; Covucci A; Martini A; Giannini EH; ;
    Lancet; 2008 Aug; 372(9636):383-91. PubMed ID: 18632147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use.
    Proudman SM; James MJ; Spargo LD; Metcalf RG; Sullivan TR; Rischmueller M; Flabouris K; Wechalekar MD; Lee AT; Cleland LG
    Ann Rheum Dis; 2015 Jan; 74(1):89-95. PubMed ID: 24081439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
    Rachmilewitz D
    BMJ; 1989 Jan; 298(6666):82-6. PubMed ID: 2563951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment.
    Taylor HG; Beswick EJ; Dawes PT
    Clin Rheumatol; 1991 Mar; 10(1):43-8. PubMed ID: 1676621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect.
    Corkill MM; Jobanputra P; Gibson T; Macfarlane DG
    Br J Rheumatol; 1990 Feb; 29(1):41-5. PubMed ID: 1968354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group.
    J Rheumatol; 1992 Nov; 19(11):1672-7. PubMed ID: 1362778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: A Double-Blind, Randomized Controlled Trial.
    Javadi F; Ahmadzadeh A; Eghtesadi S; Aryaeian N; Zabihiyeganeh M; Rahimi Foroushani A; Jazayeri S
    J Am Coll Nutr; 2017 Jan; 36(1):9-15. PubMed ID: 27710596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis.
    Kruis W; Judmaier G; Kayasseh L; Stolte M; Theuer D; Scheurlen C; Hentschel E; Kratochvil P
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):391-6. PubMed ID: 7614099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.